The Texas plant is the company's 10th U.S. manufacturing site announced since 2020. This project is part of a broader $50 billion investment program focused on increasing domestic production capacity for the pharmaceutical manufacturer.
Tuesday, October 20, 2026
Story
Eli Lilly Breaks Ground on $6.5 Billion Houston Plant for 10th US Site Since 2020
Business29 days ago
Eli Lilly has started construction on a 1 million square foot manufacturing facility in Houston to produce its FDA approved oral weight loss pill Foundayo. The $6.5 billion investment creates 615 permanent jobs and approximately 4,000 construction roles over a 5 year build out. The site will produce active pharmaceutical ingredients for Foundayo alongside other small molecule and advanced medicines.
Looking for more context or analysis?
Tilt chat provides reliable, tailored insights, alerts, and automations.